Intelligent Control of Manufacturing ICM Workshop

1
What is ATP to Someone in CBM?
2
ATP Mission

• The ATP does
• Fund applied RD where underlying science is
  known and there are clear objectives
• Insist that project proposals present a clear,
  coherent research plan illustrating how technical
  uncertainties will be tackled
• Manage awards with cooperative agreements that
  allow the ATP to be a partner
• Encourage companies to work together as
  collaborative RD partners

3
ATP Mission

• The ATP does NOT
• Supplant private capital
• Fund basic research
• Fund product development

4
ATP Stimulates Economic Growth
Company Profits
ATP
U.S. Economic Benefits
Technology based product/service
RD
Company
Diffusion of Knowledge
5
The Difference ATP Makes

• High risk
• Leap-frog technology
• Multiple applications
• Expanding company
• national competencies
• Broad diffusion

Without ATP

• Low risk
• State-of-art technology
• Single application
• Core competency of
• company
• No diffusion

ATP
6
ATP Partners
Universities
Consortia
Industry ATP
Not-for Profits
Federal Labs
The Alliance Network www.atp.nist.gov/alliance/w
elcome.htm
7
Status of ATP

• Our Status to Date
• 3,585 proposals submitted by industry
• 431 projects co-funded with 1,010 participants
• 2.783 billion of advanced technology development
  funded
• ATP Share 1.386 billion
• Industry Share 1.397 billion

8
Our Partners

• Our Partners
• Small businesses are thriving
• gt 50 of projects led by small businesses
• Joint ventures have many small business
  participants
• Universities play a significant role
• gt 125 different universities involved
• gt 400 instances of participation
• Federal laboratories participate

9
Benefits of Partnership
Partnering with the ATP

• Facilitates and accelerates high risk research
• Stimulates collaboration
• Shortens RD cycle
• Accelerates commercialization of the ATP-related
  technology
• Improves competitive standing

10
ATP Criteria
What We Look For in a Proposal

• Scientific and Technological Merit (50)
• Innovations in the Technology
• High Technical Risk Feasibility
• Quality of RD Plan

Technology
Economics

• Broad-Based Economic Benefits (50)
• Economic Benefits
• Need for ATP funding
• Pathway to Economic Benefit

11
Broad-Based Economic Benefits
What is an Enabling Technology?

• Pathbreaking technology
• Opens up new possibilities
• Revolutionary in nature
• Infrastructural technology
• Supports RD, production and business of an
  entire industry
• Multi-use technology
• Many distinct applications

12
Pathway to Economic Benefit
Commercialization Plan and Strategy

• Identifies target applications secondary
  applications
• Demonstrates understanding of markets
• Details company strengths and weaknesses
• Analyzes competitiveness timeliness
• Explores strategic alliances

13
High Technical Risk and Feasibility

• High Technical Risk
• Does the proposed project go beyond current state
  of the art?
• Do the technical challenges indicate significant
  uncertainty of success?
• Would success dramatically change the future
  direction of technology and its market impact?
• Risk can be in developing simple innovations
  and/or integrating technologies

14
High Technical Risk and Feasibility

• Feasibility
• Is the proposed technical approach credible?
• Are anticipated solutions based on sound
  technology and innovation?
• Is there a reasonable balance between technical
  risk, feasibility and payoff?

15
1999 Competition

• FY 1999 Competition
• Competition 99-01
• Proposals due April 14, 1999 at 3 p.m. Eastern
  Time
• 66 million in first-year funding for new awards

16
FY 1999 CompetitionChanges

• Whats New in FY 1999 . . .
• 66 Million in first-year funding leverages
  350-450 Million in RD investment
• Technology-Specific Source Evaluation Boards
• Two Selection Criteria Weighted Equally
• Scientific and Technological Merit
• Broad-Based Economic Benefits
• Continuous Pre-proposal Evaluation (optional)
• Large Company Defined by Revenue of 2.721 Billion

17
ANSWERING THE QUESTION
18
TUESDAYS AGENDA

• 800 am Registration
• 900 am Opening Remarks and Introductions
• Lura Powell, Director, ATP/NIST
• Chuck Bartholomew, Program Manager, ATP/NIST
• Key Note Addresses
• 915 am 5 -10 Year Vision for CBM, an Industrial
  Perspective
• John Mitchell, President, MIMOSA
• 1000 am Discussion
• 1015 am Morning Break

19
TUESDAYS AGENDA

• Key Note Addresses (continued)
• 1045 am Current Research and Research Needs in
  CBM
• David Thurston, Program Manager, ONR
• 1130 am Discussion
• 1145 am ATP Update, Changes and Program
  Planning
• John Gudas, Office Director, ATP/NIST
• 1215 pm Discussion
• 1230 pm Lunch
• Lunch time presentation???

20
TUESDAYS AGENDA

• 130 pm Breakout Sessions (in parallel)
• A. Prognostication Capabilities
• Facilitator Chuck Bartholomew, ATP/NIST
• B. Sensors/Transducers for Monitoring Machine
  Health
• Facilitator Clare Alloca, ATP/NIST
• C. Integration and Reasoning Systems
• Facilitator Barbara Cuthill, ATP/NIST
• 300 pm Afternoon Break
• 330 pm Breakout Sessions Reports, Discussion of
  Results
• 530 pm Adjourn

21
The ATP Sweet Spot
22
SIFTING THROUGH IDEAS

• Roadmaps
• Workshops
• Conferences
• Literature
• National Labs
• Individuals
• Government
• Associations
• Consortia
• Universities
• Companies
• RD Efforts